Americas COVID-19 Testing Market valuation is at US$ 5.1 Billion in 2022 and likely to be valued at US$ 9.8 Billion by 2033. The sales of America’s COVID-19 testing are growing at a CAGR of 6.7% during the forecast period. The growing number of COVID-19-infected patients, treatment procedures, and R&D activities are increasing the demand for …
Monthly Archives: July 2023
With an 8.1% CAGR from 2022 to 2032, the skin care industry will reach US$ 230.21 Billion in global size | FMI
The global Skincare Market is expected to grow at an 8.1% CAGR between 2022 and 2032. The market is expected to reach US$ 131 billion by 2022. Because of rising demand and growth, the global skincare industry is expected to reach US$ 230.21 billion by 2032. Personalized things are becoming increasingly popular among Americans. Serums, creams, and …
According to FMI Report | Nasal Spray Market continually growing CAGR of 6.2% to Achieve valuation of US$ 32.6 Billion by 2033
Future Market Insights (FMI) has forecast positive outlook for the Nasal Spray Market in a recent study. The rising cases of allergic rhinitis and the demand for better accuracy in drug delivery are identified as chief growth drivers. Growth is expected to remain bullish as various countries showcase high healthcare spending. The global market is expected to …
Ocular Drug Delivery System Market demand at a CAGR of 6.9% by 2033 with expected valuation of US$ 31,410.2 Million | As per FMI Study
The Ocular Drug Delivery System Market is forecast to surpass US$ 16,159.9 million in 2023, according to Future Market Insights. Due to the rising cases of ophthalmic diseases, the focus on advanced treatment is rising, enabling a surge in ocular drug delivery systems demand at a CAGR of 6.9% between 2023 and 2033. To overcome the ocular …
Ophthalmic Eye Drops predicted to progress at a CAGR of 4.2% to achieve a valuation of US$ 24.53 Billion by 2033 | FMI
To treat ocular conditions or regain normal eye function, Ophthalmic Eye Drops are used to deliver medications locally in the ocular cavities. Topical instillation of eye drops is the most popular and straightforward method of ocular drug administration, and it serves as the preferred course of treatment. Globally, it is anticipated that eye infections will become more …
Pelvic Floor Stimulators are expected to reach a valuation of US$ 325.41 Million by 2033 and grow at a CAGR of 8.8% | According to FMI
According to a recent report by FMI, the sector for Pelvic Floor Stimulators is expected to generate global sales of US$ 140.39 million in 2023. The market’s demand outlook is still positive, and according to FMI, it will grow at an 8.8% CAGR from 2023 to 2033, reaching US$ 325.41 million by that time. Weakening …
Stereotactic Planning Software likely to secure a CAGR of 4.8% through 2033 and estimated to cross US$ 442.1 Million by 2033 | FMI
The market for Stereotactic Planning Software is anticipated to grow at a CAGR of 4.8% from 2023 to 2033. From US$ 276.5 million in 2013 to US$ 442.1 million in 2033, the market is projected to increase. The high prevalence of neurological disorders and small cell lung cancer is expected to boost the demand in …
Value-Based Healthcare Services Market is expected to reach a valuation of US$20.5 Billion by 2033, growing at a CAGR of around 21.1% | FMI
The Value-Based Healthcare Services Market is anticipated to be worth US$ 20.5 billion. As they provide various payment models such accountable care organisations, bundled payments, pay-for-performance, and patient-centered medical homes, value-based healthcare services are becoming more and more in demand. The services they provide frequently depend on what the customers want. Also, the global market for …
By 2033, the market for 3D bioprinting is expected to grow at a CAGR of 12.6% and reach US$ 6.5 Billion | FMI
From 2023 to 2033, the 3D Bioprinting Market is anticipated to expand at a CAGR of 12.6%. As of 2023, the market is valued at $2 billion USD. The market is anticipated to be worth US$ 6.5 billion by 2033. Academic institutes and hospitals use 3D printing technology to develop various models for training purposes. The technology …
With a CAGR of 6.7% throughout the projected period, the Americas COVID-19 Testing Market is anticipated to reach US$ 9.8 Billion in value by 2033 | FMI
Americas COVID-19 Testing Market valuation is at US$ 5.1 Billion in 2022 and likely to be valued at US$ 9.8 Billion by 2033. The sales of America’s COVID-19 testing are growing at a CAGR of 6.7% during the forecast period. The growing number of COVID-19-infected patients, treatment procedures, and R&D activities are increasing the demand for …